Sitagliptin Protects Cardiac Function by Reducing Nitroxidative Stress and Promoting Autophagy in Zucker Diabetic Fatty (ZDF) Rats Yi ZhouHuanyuan WangWen Wang ORIGINAL ARTICLE 16 October 2018 Pages: 541 - 552
Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation Yumei YeXiaoming JiaYochai Birnbaum ORIGINAL ARTICLE 26 October 2018 Pages: 553 - 558
Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients Vasilios SimopoulosAthanasios HevasIsaac Aidonidis ORIGINAL ARTICLE 25 September 2018 Pages: 559 - 565
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial Paolo ZoccaMarlies M. KokClemens von Birgelen ORIGINAL ARTICLE Open access 24 August 2018 Pages: 567 - 576
Heart Failure with Preserved Ejection Fraction Trials Have Heterogeneous Control Groups: a Comparison of Kaplan-Meier Curves Hongxing LuoCong ZhangXingtai Jia SHORT COMMUNICATION 05 September 2018 Pages: 577 - 580
A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Protection Union Study (CAMPUS) Jianning ZhangYijia ShaoJun Tao ORIGINAL ARTICLE 05 September 2018 Pages: 581 - 589
Predictors of Major Bleeding Among Working-Age Adults with Atrial Fibrillation: Evaluating the Effects of Potential Drug-drug Interactions and Switching from Warfarin to Non-vitamin K Oral Anticoagulants Xue FengUsha SambamoorthiXi Tan ORIGINAL ARTICLE 12 October 2018 Pages: 591 - 600
Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction Lisandro D. ColantonioLuqin DengRobert S. Rosenson ORIGINAL ARTICLE 16 November 2018 Pages: 601 - 610
Food as Medicine for Secondary Prevention of Cardiovascular Events Following an Acute Coronary Syndrome Vijayapraveena ParuchuriJuan GaztanagaMichael E. Farkouh ORIGINAL ARTICLE 13 June 2018 Pages: 611 - 616
Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application S. BouchezF. FedeleC. Tschöpe REVIEW ARTICLE Open access 06 November 2018 Pages: 617 - 624
Use of Fentanyl During Percutaneous Coronary Interventions: Safety and Drawbacks Marco ZuinGianluca RigatelliLoris Roncon REVIEW ARTICLE 24 October 2018 Pages: 625 - 632
Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)? Rosa AhnVinay Prasad LETTER TO THE EDITOR 19 September 2018 Pages: 633 - 635
Correction to: Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)? Rosa AhnVinay Prasad Correction 01 October 2018 Pages: 637 - 637
Publisher Correction: Exposure to Stress-Dose Steroids and Lethal Septic Shock After In-Hospital Cardiac Arrest: Individual Patient Data Reanalysis of Two Prior Randomized Clinical Trials that Evaluated the Vasopressin–Steroids–Epinephrine Combination Versus Epinephrine Alone Spyros D. MentzelopoulosIosifina KoliantzakiSpyros G. Zakynthinos Publisher Correction 19 September 2018 Pages: 639 - 641
